Therapeutic Antibodies for Cancer Part 1 Flashcards

1
Q

Define Tumor Targeting Antibodies

A

Monoclonal antibody designed to target oncoproteins expressed by tumor cells and to cause an immune response that destroys cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Immunomodulatory Antibody:

A

Monoclonal antibodies specifically interacts with immuno-regulatory molecules, which elicits or restores an existing anti-cancer immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define Adoptive T cell Transfer:

A

A treatment using host T cells to boost the natural ability of immune activity to fight cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define Immunostimulatory Cytokines:

A

Multiple functional proteins that play important roles in body’s immune responses and have the immune-regulatory activity to control cancer cell growth. The two main types of cytokines used to treat cancer are interferon-α/β and interleukin-2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define Cancer-Therapeutic Vaccines:

A

Antigen-presenting cells (APC) to stimulate immune response against cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define Innate Immunity Agonists:

A

Bacillus Calmette-Guérin (BCG): An innate immunity-stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define Monoclonal Antibodies (mAbs):

A

Produced from a single B lymphocytes, either from mouse, human or other species.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define Murine mAbs

A

Derived entirely from mouse, usually mouse hybridoma cells by the fusion of mouse myeloma cells with spleen B-cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define Chimeric mAbs:

A

Variable regions derived from a murine source and the constant regions derived from a human source.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define Humanized mAbs:

A

Antigen-binding sequences (CDRs) derived from a mouse and all others from a human source. (less mouse, more human)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define Human mAbs:

A

Derived entirely from a human source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define Naked Therapeutic Antibody

A

Simple antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define Conjugated Therapeutic Antibody

A

Antibody carrying chemotherapy or isotopes (ADC or AIC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define Immuno-Regulatory Therapeutic Antibody

A

Remove the inhibitory signals and restore T cell response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define Bispecific Antibody

A

One side interacts with T cell immune response and the other carries chemotherapy or isotopes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immuno-Regulatory Therapeutic Antibody Drugs

A

Ipilimumab (CTLA-4 inhibitor)

Nivolumab and pembrolizumab (PD-1 inhibitor)

17
Q

Naked Antibody Drugs

A

Trastuzumab (HER2)

Cetuximab (EGFR)

18
Q

ADC Drugs

A

Ado-Trastuzumab emansine (HER2)

19
Q

When EGFR is activated…

A

it will increase the oncogenic cell signals to make the cell proliferate a lot faster or metastasis much more aggressive (so if you block this you can treat cancer

20
Q

Transtuzumab Brand Name, Antibody Type and Target

A

Herceptin
Humanized mouse mAb
HER2

21
Q

Transtuzumab Indication

A

Adjuvant breast cancer

Metastatic Breast Cancer

22
Q

Transtuzumab AE

A

Cardiomyopathy

Pulmonary toxicity

23
Q

Cetuximab Brand Name, Antibody Type and Target

A

Erbitux
Chimeric mAb
EGFR

24
Q

Cetuximab Indication

A

Head and Neck Cancer

Colorectal Cancer WITHOUT KRAS mutation

25
Q

KRAS mutation leads to

A

Upon activation through mutation, it causes increased proliferation and no longer needs EGFR to activate it

26
Q

Cetuximab AE

A

Cardiopulmonary
Pulmonary toxicity
Dermatologic toxicity

27
Q

Ado-Trastuzumab Ematansine (T-DM1) Brand Name, Antibody Type and Target

A

Kadcyla
Humanized mAb conjugated with a highly potent chemical maytansinoid (DM1)
HER2

28
Q

T-DM1 Indication

A

HER2 Positive Metastatic Breast Cancer

29
Q

T-DM1 AE

A

Hepatoxicity
Cardiotoxicity
Embryo-fetal toxicity

30
Q

Bevacizumab Brand Name, Antibody Type and Target

A

Avastin
Humanized mAb
Specific for VEGF not the receptor

31
Q

Bevacizumab Indication

A
  • Metastatic colorectal cancer
  • Non-squamous non-small cell lung cancer
  • Glioblastoma
  • Metastatic renal cell carcinoma
32
Q

Bevacizumab AE

A

GI performation
Wound healing complication
Hemorrhage

33
Q

What is the purpose of VEGF

A

Regulate/stimulate new blood vessel production